Le, Thuc M.
Poddar, Soumya
Capri, Joseph R.
Abt, Evan R.
Kim, Woosuk
Wei, Liu
Uong, Nhu T.
Cheng, Chloe M.
Braas, Daniel
Nikanjam, Mina
Rix, Peter
Merkurjev, Daria
Zaretsky, Jesse
Kornblum, Harley I.
Ribas, Antoni
Herschman, Harvey R.
Whitelegge, Julian
Faull, Kym F.
Donahue, Timothy R.
Czernin, Johannes
Radu, Caius G. http://orcid.org/0000-0002-9338-5397
Article History
Received: 20 October 2016
Accepted: 13 June 2017
First Online: 14 August 2017
Competing interests
: The authors declare the following competing financial interest(s): C.G.R. and J.C. are co-founders of Trethera Corporation. They and the University of California hold equity in Trethera Corporation. The University of California has patented additional intellectual property for small molecule dCK inhibitors invented by C.G.R., J.C., S.P. and T.M.L. This intellectual property has been licensed by Trethera Corporation.